tiprankstipranks
Trending News
More News >
Hepion Pharmaceuticals (HEPA)
OTHER OTC:HEPA
US Market
Advertisement

Hepion Pharmaceuticals (HEPA) Ownership - Who Owns Hepion Pharmaceuticals?

Compare
790 Followers

Hepion Pharmaceuticals (HEPA) Ownership Overview

8.11%91.89%
8.11% Other Institutional Investors
91.89% Public Companies and
Individual Investors
The ownership structure of Hepion Pharmaceuticals (HEPA) stock is a mix of institutional, retail, and individual investors. , and 91.89% is owned by Public Companies and Individual Investors.
The ownership structure of Hepion Pharmaceuticals (HEPA) stock is a mix of institutional, retail, and individual investors. , 8.11% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
12,059Insider0.11%2,207
7,008Insider0.07%1,282
979Institution<0.01%62
979Institution<0.01%69

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
979Institution<0.01%62

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Hepion Pharmaceuticals (HEPA)?
Currently, no data Available
What percentage of Hepion Pharmaceuticals (HEPA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 8.11% of Hepion Pharmaceuticals (HEPA) stock is held by institutional investors.
    What percentage of Hepion Pharmaceuticals (HEPA) stock is held by retail investors?
    According to the latest TipRanks data, approximately 91.89% of Hepion Pharmaceuticals (HEPA) stock is held by retail investors.
      Who owns the most shares of Hepion Pharmaceuticals (HEPA)?
      Gary Jacob owns the most shares of Hepion Pharmaceuticals (HEPA).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis